Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Influenza Vaccine - Introduction

4. Market Dynamics
    4.1 Drivers
          4.1.1 Increasing Initiatives for Creating Awareness
          4.1.2 Precipitous Rise in Influenza Cases
          4.1.3 Investments by Organizations
          4.1.4 Increasing Government  Initiatives for Influenza Vaccination Coverage
          4.1.5 Growing Affordability for Expensive Drugs
    4.2 Challenges
          4.2.1 Expensive and Time Consuming Manufacturing Processes
          4.2.2 Lack of  Proper Infrastructure
    4.3 Opportunities
          4.3.1 Surging Demand by Ageing Population
          4.3.2 Explosive Population Growth
          4.3.3 Innovative Technologies Boosting Influenza Vaccine Production
    4.4 Trends
          4.4.1 Collaboration & Consolidation
          4.4.2 Upsurge in the Number of Product Launches

5. Indian Influenza Market Outlook 2020
    5.1 Value Market
    5.2 Unit Volume Market
    5.3 Indian Influenza Market by Product
         5.3.1 Vaxigrip
         5.3.2 Influvac
         5.3.3 Others
    5.4 Potential Market

6. Market Insights
    6.1 Pricing Analysis
    6.2 Distribution and Supply Chain
    6.3 Cold Storage Overview

7. Competitive Landscape
    7.1 Share of Major Players

8. Key Players Analysis
    8.1 Cipla Limited
    8.2 Bharat Biotech
    8.3 Panacea Biotec Limited
    8.4 Zydus Cadilla
    8.5 Lupin Ltd.
    8.6 Abbott Laboratories
    8.7 GlaxoSmithKline Plc (GSK)
    8.8 Sanofi
    8.9 CPL Biologicals Pvt. Ltd.
    8.10 Serum Institute of India
    8.11 Seqirus - A CSL Company